The University of Southampton
University of Southampton Institutional Repository

Individualizing the risks and benefits of postmenopausal hormone therapy

van Staa, Tjeerd P., Cooper, Cyrus, Barlow, David and Leufkens, Hubert G.M. (2008) Individualizing the risks and benefits of postmenopausal hormone therapy Menopause, 15, (2), pp. 374-381. (doi:10.1097/gme.0b013e31812e558f).

Record type: Article


Objective: The objective was to develop an individualized risk-benefit model quantifying the impact of combined use of estrogen and progestogen on chronic diseases.

Design: The study population consisted of women, aged 40+, prescribed postmenopausal hormone therapy (HT) in the UK General Practice Research Database (N > 200,000). Individualized risks of fracture, colorectal cancer, diabetes mellitus, myocardial infarction, deep venous thrombosis/pulmonary embolism, breast cancer, and stroke were estimated using Cox regression. Relative rates from the Women's Health Initiative trial were used to estimate attributable risks (ie, excess risks) in a risk-benefit simulation model.

Results: Risks and benefits increased with age and length of HT use. HT use for 5 years initiated at age 45 increased the absolute risk of myocardial infarction by 0.04% and breast cancer by 0.3% and reduced the risk of hip fracture by 0.03%. Comparably, 5-year HT use started at age 75 led to increases in the risks of myocardial infarction and breast cancer (+0.4% and +0.2%, respectively) and reduced that of hip fracture (-0.9%). There was considerable heterogeneity in the risks and benefits of HT. In most of the younger HT users, the frequency of risks exceeded that of the benefits, although the absolute excess risks were small. In HT users aged 70+, 62.4% experienced more benefits than risks, whereas 37.6% experienced more risks than benefits.

Conclusions: The frequency of beneficial and adverse effects of HT on chronic diseases was low in younger women, whereas the ratio of these risks and benefits varied substantially among the older users. However, the study could not asses the effects of HT on menopausal symptoms and quality of life, benefits more likely to be observed among younger women.

Full text not available from this repository.

More information

Published date: March 2008
Keywords: stroke, bone, hip, chronic disease, breast cancer, adverse effects, cancer, quality of life, research, risk, diabetes, embolism, aged, myocardial infarction, health, women, diabetes mellitus, therapy, disease


Local EPrints ID: 61580
ISSN: 1072-3714
PURE UUID: e21e9dbb-1df4-460f-b42b-3288fa3de9ce
ORCID for Cyrus Cooper: ORCID iD

Catalogue record

Date deposited: 10 Oct 2008
Last modified: 17 Jul 2017 14:21

Export record



Author: Tjeerd P. van Staa
Author: Cyrus Cooper ORCID iD
Author: David Barlow
Author: Hubert G.M. Leufkens

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton:

ePrints Soton supports OAI 2.0 with a base URL of

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.